For the Inventor, By the Inventor

Enter assignee name

Watertown, MA, United States of America

Kymera Therapeutics, Inc.

USPTO Granted Patents = 35

EPO Patents = 1

Trademarks = 3

Forward Citations = 141

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Nan Ji (23 out of 46 patents)

Nello Mainolfi (20 out of 41 patents)

Yi Zhang (19 out of 25 patents)

4. Matthew M Weiss (19 out of 51 patents)

5. Arthur F Kluge (15 out of 96 patents)

6. Xiaozhang Zheng (10 out of 105 patents)

7. Xiao Zhu (6 out of 12 patents)

8. Bin Yang (3 out of 3 patents)

9. Haojing Rong (3 out of 3 patents)

10. Paul R Fleming (2 out of 2 patents)

11. Duncan Walker (1 out of 10 patents)

12. Arthur F Fluge (1 out of 1 patent)

13. Don Corson (1 out of 1 patent)

14. Jeffrey Davis (1 out of 4 patents)

15. Brad Enerson (1 out of 1 patent)

35 patents: Sort by Forward Citations

1. 12516068 - Protein degraders and uses thereof (2026-01-06),

2. 12497402 - IRAK4 degraders and uses thereof (2025-12-16),

3. 12454520 - Protein degraders and uses thereof (2025-10-28),

4. 12258341 - IRAK degraders and uses thereof (2025-03-25),

5. 12187744 - IRAK4 degraders and synthesis thereof (2025-01-07),

6. 12171768 - IRAK4 degraders and uses thereof (2024-12-24),

7. 12168057 - IRAK degraders and uses thereof (2024-12-17),

8. 12150995 - IRAK degraders and uses thereof (2024-11-26),

9. 12097261 - CDK2 degraders and uses thereof (2024-09-24),

10. 12091411 - IRAK degraders and uses thereof (2024-09-17),

11. 12077555 - STAT degraders and uses thereof (2024-09-03),

12. 12006329 - Protein degraders and uses thereof (2024-06-11),

13. 11932635 - CRBN ligands and uses thereof (2024-03-19),

14. 11932624 - MDM2 degraders and uses thereof (2024-03-19),

15. 11897882 - Tricyclic crbn ligands and uses thereof (2024-02-13),

Kymera Therapeutics is a biotechnology company focused on developing breakthrough medicines that can selectively degrade disease-causing proteins. Using its proprietary targeted protein degradation platform, Kymera is able to discover and develop small molecules that can remove specific proteins from the body, offering a new approach for treating a wide range of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

35 Patents

#11 in Watertown, MA

#554 in Massachusetts

#9,428 in US

#18,625 in the World

Watertown, MA, United States of America

Kymera Therapeutics, Inc.

Forward Citations = 141

24 inventors:

Nan Ji (23 out of 46 patents)

Nello Mainolfi (20 out of 41 patents)

Yi Zhang (19 out of 25 patents)

4. Matthew M Weiss (19 out of 51 patents)

5. Arthur F Kluge (15 out of 96 patents)

Please report any incorrect information to support@idiyas.com

Loading…